(Q39450684)

English

Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

RNA interference

1 reference

based on heuristic

inferred from title

author name string

Wei Jiang

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Zhiming Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Xinying Li

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jindong Li

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yun Huang

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Xuegong Fan

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yankun Duan

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

26 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

92-98

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

https://scigraph.springernature.com/pub.10.1007/s10620-011-1944-z

0 references

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Evolution of systemic therapy of advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Strategies for silencing human disease using RNA interference

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

RNA interference in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

The promises and pitfalls of RNA-interference-based therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Nonhistone Proteins HMG 1 and HMG 2 Change the DNA Helical Structure

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

HMGB1 is an endogenous immune adjuvant released by necrotic cells

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Masquerader: high mobility group box-1 and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Molecular mechanisms of hepatic metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Mechanics, malignancy, and metastasis: the force journey of a tumor cell

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

High-mobility group box 1 and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Nf-kappa B, chemokine gene transcription and tumour growth

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Knocking down barriers: advances in siRNA delivery

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Dual roles for HMGB1: DNA binding and cytokine

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1944-Z

21 January 2018

Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effect of HMGB1-siRNA on proliferation and apoptosis of HepG2 cells]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effect of HMGB1 on human hepatoma cell line-HepG2 proliferation].

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual roles for HMGB1: DNA binding and cytokine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22038506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-011-1944-Z

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39450684&oldid=1587921880"